Brief Inhibitory Training for Eating - Intervention
Part of paid clinical trials in Fairfax, Virginia.
- Sponsor
- George Mason University
- Study ID
- NCT07592728
- Status
- Recruiting
Conditions
- Overweight and/or Obesity
Eligibility Criteria
- Sex
- ALL
- Age
- 14 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Daily inhibitory control training — BEHAVIORALChildren will first complete a short nutrition education then complete daily 10-minute inhibitroy control training each day for 10 minutes across 3 weeks
Study Details
The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training. Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life. Aim 2 is to evaluate the efficacy of IC training for modifying the hypothesized intervention mechanism: food-related IC and eating regulation. In the study, participants will: Complete questionnaires and cognitive tasks Receive a short nutrition education Complete three weeks of daily brain games on your phone
Key Dates
- First listed
- May 18, 2026
- Start date
- May 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Feb 10, 2027
- Completion
- Mar 10, 2027
Study Design
- Enrollment
- 36 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Inhibitory control training
Primary Outcome Measure
Inhibitory control [ Time Frame: 1 month ]
Central Contacts
- Tyler Mason, PhD703-993-1000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| George Mason University | Fairfax | Virginia | 22030 | Tyler Mason |
Find similar trials in Fairfax, VA
By research site
Related Studies
- A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)PHASE2 · Recruiting · Pfizer · Chandler, Arizona
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityPHASE3 · Recruiting · Pfizer · Modesto, California
- Optimization of Dietary Adherence in a Mobile Weight Loss InterventionNot Yet Recruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina
- Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese ParticipantsPHASE1 · Recruiting · Terrestrial Bio, Inc. · Tempe, Arizona